Page 28«..1020..27282930..4050..»

Category Archives: Muscular Dystrophy Treatment

Advocates seek homes for research dogs and cats – The Salem News

Posted: Published on September 21st, 2019

BOSTON Thousands of cats and dogs used in medical research are eventually euthanized, according to animal advocates who for years have lobbied the scientific community to instead find homes for them. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Advocates seek homes for research dogs and cats – The Salem News

This Biotech Targets Mitochondria to Treat Inherited… – Labiotech.eu

Posted: Published on September 21st, 2019

As we come to the end of the global Mitochondrial Disease Awareness Week, its time to visit Khondrion. This Dutch company is developing drugs to treat rare diseases such as MELAS syndrome by targeting defective mitochondria Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on This Biotech Targets Mitochondria to Treat Inherited… – Labiotech.eu

CureDuchenne Appoints Lianna Orlando, PhD, to the Position of Senior Director of Research – Business Wire

Posted: Published on September 21st, 2019

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--CureDuchenne, the leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, announced today that Lianna Orlando, PhD has joined the team as Senior Director of Research. In this role, Orlando will help identify and evaluate strategic investments aimed at developing treatments for Duchenne muscular dystrophy. We are very excited to have Lianna join our team she has exactly the skill set we need to find and evaluate the most promising Duchenne research from around the world that has the most potential to achieve our goal of improving and extending the lives of those affected by Duchenne muscular dystrophy, said Debra Miller, founder and CEO, CureDuchenne. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on CureDuchenne Appoints Lianna Orlando, PhD, to the Position of Senior Director of Research – Business Wire

Here’s Why PTC Therapeutics Fell as Much as 12.5% Today – Motley Fool

Posted: Published on September 21st, 2019

What happened Shares of PTC Therapeutics (NASDAQ:PTCT) fell more than 12% after the company announced the pricing of a debt offering and a share offering. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Here’s Why PTC Therapeutics Fell as Much as 12.5% Today – Motley Fool

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, ABMD and SRPT – Yahoo Finance

Posted: Published on September 21st, 2019

NEW YORK, NY / ACCESSWIRE / September 20, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of JE, ABMD and SRPT – Yahoo Finance

CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – Yahoo Finance

Posted: Published on September 21st, 2019

NEW YORK, NY / ACCESSWIRE / September 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. To determine your eligibility and get free access to our shareholder support tools that provide you with case updates, automated loss calculations and claims recovery assistance, please contact the firm via the links below Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on CLASS ACTION UPDATE for GTT, TWOU and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders – Yahoo Finance

Boulder-based Edgewise Therapeutics raises $50M in Series B round – BizWest

Posted: Published on September 21st, 2019

BOULDER Edgewise Therapeutics Inc. closed a $50 million Series B fundraising round for its research into musculoskeletal diseases. According to a press release, Edgewise said the funding will be used to prepare its main drug candidate, a treatment for two forms of muscular dystrophy, for clinical trials. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Boulder-based Edgewise Therapeutics raises $50M in Series B round – BizWest

The wearable cyborgs that use brain waves to power up your muscles – WTOP

Posted: Published on September 21st, 2019

HAL helps those with spinal cord injuries and muscular dystrophy regain their movements and strengthen their nerves and muscles. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on The wearable cyborgs that use brain waves to power up your muscles – WTOP

Jane’s Journey: Genetic condition doesn’t stop this 2-year-old, who is ‘ready, set, go’ – Grand Forks Herald

Posted: Published on September 21st, 2019

Family and friends tried to encourage parents Megan and Bryant Comfort that their baby girl would be alright, but they soon learned that Jane had Spinal Muscular Atrophy. The condition is a genetic disease affecting the part of the nervous system that controls voluntary muscle movement, according to the Muscular Dystrophy Association. What that meant for Jane was that she was essentially paralyzed by the time she was three months old. Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Jane’s Journey: Genetic condition doesn’t stop this 2-year-old, who is ‘ready, set, go’ – Grand Forks Herald

Clinical Catchup: September 16-20 – BioSpace

Posted: Published on September 21st, 2019

Last week was an unusually busy week for clinical trial news, with numerous companies presenting results at conferences. Heres a look at the top stories Continue reading

Posted in Muscular Dystrophy Treatment | Comments Off on Clinical Catchup: September 16-20 – BioSpace

Page 28«..1020..27282930..4050..»